Please login to the form below

Not currently logged in

Novo Holdings

This page shows the latest Novo Holdings news and features for those working in and with pharma, biotech and healthcare.

Novo launches $165m antimicrobial resistance initiative

Novo launches $165m antimicrobial resistance initiative

The REPAIR fund is the brainchild of Novo Holdings, the major shareholder in the Novo Group companies and will focus on priority pathogens, which the World Health Organization (WHO) defines as ... Kasim Kutay, chief executive officer of Novo Holdings,

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    These initiatives have been recently joined by a $165m ‘REPAIR’fund from Novo Holdings, as an investment in companies involved in discovery and early-stage development of therapies to combat antimicrobial

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    2. and CKD. 3. 198. Zosano (formerly Macroflux) / Novo Nordisk. ... UDG subsidiaries : The Specials Laboratory Holdings, Craig &Hayward, Arjun Products.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....